VR Adviser as of June 30, 2025
Portfolio Holdings for VR Adviser
VR Adviser holds 31 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 27.6 | $369M | 8.5M | 43.43 | |
| Ocular Therapeutix (OCUL) | 8.9 | $118M | 13M | 9.28 | |
| Mestera (MTSR) | 8.0 | $107M | 3.8M | 28.45 | |
| Enliven Therapeutics (ELVN) | 6.1 | $81M | 4.0M | 20.06 | |
| Kalvista Pharmaceuticals (KALV) | 5.7 | $76M | 6.7M | 11.30 | |
| Oric Pharmaceuticals (ORIC) | 5.0 | $67M | 6.6M | 10.15 | |
| Miragen Therapeutics (VRDN) | 4.1 | $54M | 3.9M | 13.98 | |
| Oruka Therapeutics (ORKA) | 3.5 | $47M | 4.1M | 11.21 | |
| Spyre Therapeutics Com New (SYRE) | 3.0 | $40M | 2.7M | 14.97 | |
| Pharvaris N V (PHVS) | 2.7 | $36M | 2.0M | 17.60 | |
| Cogent Biosciences (COGT) | 2.6 | $34M | 4.8M | 7.18 | |
| Jade Biosciences Com New (JBIO) | 2.4 | $32M | 3.2M | 9.99 | |
| Cytomx Therapeutics (CTMX) | 2.4 | $32M | 14M | 2.27 | |
| Cidara Therapeutics Com New (CDTX) | 2.3 | $31M | 639k | 48.71 | |
| Upstream Bio (UPB) | 1.9 | $25M | 2.3M | 10.98 | |
| Erasca (ERAS) | 1.7 | $23M | 18M | 1.27 | |
| Crescent Biopharma (CBIO) | 1.7 | $22M | 1.4M | 16.14 | |
| Dyne Therapeutics (DYN) | 1.6 | $21M | 2.2M | 9.52 | |
| Savara (SVRA) | 1.5 | $20M | 8.9M | 2.28 | |
| Dianthus Therapeutics (DNTH) | 1.4 | $19M | 1.0M | 18.63 | |
| Engene Holdings (ENGN) | 1.4 | $18M | 5.0M | 3.64 | |
| Astria Therapeutics (ATXS) | 1.0 | $13M | 2.5M | 5.36 | |
| Cullinan Oncology (CGEM) | 0.8 | $10M | 1.4M | 7.53 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.8 | $10M | 1.3M | 7.65 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.6 | $8.0M | 750k | 10.62 | |
| Septerna (SEPN) | 0.4 | $5.7M | 541k | 10.57 | |
| Surrozen Com New (SRZN) | 0.4 | $5.7M | 633k | 8.94 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.4 | $4.9M | 4.6M | 1.05 | |
| Artiva Biotherapeutics (ARTV) | 0.2 | $2.4M | 1.6M | 1.51 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.1 | $1.2M | 987k | 1.18 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $568k | 99k | 5.76 |
